The immune-dependence of chemotherapy in experimental schistosomiasis

The immune-dependence of chemotherapy in experimental schistosomiasis

Experimental evidence indicates that immune effector mechanisms can enhance the activity of schistosomicidal drugs. Praziquantel, oxamniquine, hycanthone and antimony were less effective against Schistosoma mansoni infections in mice immunosuppressed by T cell-deprivation, than against comparable in...

Full description

Bibliographic Details
Main Author:	M. J. Doenhoff
Format:	Article
Language:	English
Published:	Instituto Oswaldo Cruz, Ministério da Saúde 1989-01-01
Series:	Memórias do Instituto Oswaldo Cruz.
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02761989000500004

Similar Items

IMMUNOSTIMULATION AS ADJUVANT FOR THE CHEMOTHERAPY OF EXPERIMENTAL SCHISTOSOMIASIS
by: Luciana M. SILVA, et al.
Published: (1997-01-01)

Experimental chemotherapy of Schistosomiasis III: laboratory and clinical trials with trichlorphone, an organophosphorus compound
by: Naftale Katz, et al.
Published: (1968-10-01)

Chemotherapy of human chronic Schistosomiasis mansoni : the immediate post-treatment immune response and its biological significance
by: Houghton, Jennifer Brenda
Published: (2010)

Optimising cluster survey design for planning schistosomiasis preventive chemotherapy.
by: Sarah C L Knowles, et al.
Published: (2017-05-01)

Recent advances in immunity to human schistosomiasis
by: Paul Hagan, et al.
Published: (1992-01-01)

Schistosomiasis mansoni: novel chemotherapy using a cysteine protease inhibitor.
by: Maha-Hamadien Abdulla, et al.
Published: (2007-01-01)

Experimental animal models in vaccination against schistosomiasis
by: Diane J. Mclaren
Published: (1989-01-01)

Human immune responses during schistosomiasis mansoni
by: Giovanni Gazzinelli, et al.
Published: (1992-06-01)

Human immune responses during schistosomiasis mansoni
by: Giovanni Gazzinelli, et al.
Published: (1992-06-01)

Immune responses following Praziquantel treatment of schistosomiasis
by: Philip, Judith Mary Dundas
Published: (2005)

Activity of the artemether in experimental schistosomiasis mansoni
by: Neusa Araújo, et al.
Published: (1991-01-01)

A Transmission Model for Schistosomiasis Mansoni with Age Dependent Exposure
by: Goddard, M. J.
Published: (1978)

Anti-embryonation immunity in murine schistosomiasis japonica (Philippines)
by: G. F. Mitchell, et al.
Published: (1995-03-01)

Interaction of Chemotherapy and the Immune Response in Experimental Malaria Infections
by: Myint, Lwin
Published: (1978)

Parasitological impact of 2-year preventive chemotherapy on schistosomiasis and soil-transmitted helminthiasis in Uganda
by: Stothard J Russell, et al.
Published: (2007-09-01)

Immune response in different clinical groups of Schistosomiasis patients
by: Giovanni Gazzinelli, et al.
Published: (1987-01-01)

Cervicovaginal Immune Activation in Zambian Women With Female Genital Schistosomiasis
by: Amy S. Sturt, et al.
Published: (2021-03-01)

Nutritional pathology during experimental Schistosomiasis mansoni
by: Robinson, Kate Louise
Published: (1996)

Studies on the Development of Resistance in Experimental Murine Schistosomiasis
by: Bickle, Q. D.
Published: (1978)

Schistosomiasis
by: J. Utzinger
Published: (2014-04-01)

Benefits of annual chemotherapeutic control of schistosomiasis on the development of protective immunity
by: Tawanda J. Chisango, et al.
Published: (2019-03-01)

Geographical distribution of intestinal schistosomiasis and soil-transmitted helminthiasis and preventive chemotherapy strategies in Sierra Leone.
by: Joseph B Koroma, et al.
Published: (2010-01-01)

Additive effect of rPb27 immunization and chemotherapy in experimental paracoccidioidomycosis.
by: Viviane C Fernandes, et al.
Published: (2011-01-01)

Monocyte and Macrophage-Mediated Pathology and Protective Immunity During Schistosomiasis
by: Camila Oliveira Silva Souza, et al.
Published: (2020-08-01)

Treatment of acute experimental schistosomiasis Tratamento da esquistossomose aguda experimental
by: Zilton A. Andrade, et al.
Published: (1989-12-01)

Oxamniquine, praziquantel and lovastatin association in the experimental Schistosomiasis mansoni
by: Neusa Araújo, et al.
Published: (2008-08-01)

Association of oxamniquine praziquantel and clonazepam in experimental Schistosomiasis mansoni
by: Neusa Araujo, et al.
Published: (2008-12-01)

Brain schistosomiasis in mice experimentally infected with Schistosoma mansoni
by: José Roberto Lambertucci, et al.
Published: (2014-05-01)

The role of BATF2 during of experimental murine Schistosomiasis
by: Mpotje, Thabo Rantanta Victor
Published: (2018)

In vivo kinetics of eosinophils and mast cells in experimental murine Schistosomiasis
by: H. L. Lenzi, et al.
Published: (1987-01-01)

Factors affecting the uptake of preventive chemotherapy treatment for schistosomiasis in Sub-Saharan Africa: A systematic review.
by: Carlos A Torres-Vitolas, et al.
Published: (2021-01-01)

Experimental studies of the effect of cancer chemotherapy on cellular immunity and its modification
by: Fraser, Ian
Published: (1983)

schistosomiasis
Published: (2007-10-01)

Schistosomiasis
by: Eka Husnawati, et al.
Published: (2016-06-01)

Schistosomiasis
Published: (2012)

The Antitumor Activity of Combinations of Cytotoxic Chemotherapy and Immune Checkpoint Inhibitors Is Model-Dependent
by: Chloé Grasselly, et al.
Published: (2018-10-01)

Molecular and cellular basis of hepatic fibrogenesis in experimental schistosomiasis mansoni infection
by: David J. Wyler
Published: (1992-01-01)

Current Understanding of Immunity Against Schistosomiasis: Impact on Vaccine and Drug Development
by: Molehin AJ
Published: (2020-11-01)

Protective immunity of single and multi-antigen DNA vaccines against schistosomiasis
by: E Nascimento, et al.
Published: (2002-10-01)

The stabilizing effects of the acquired immunity on the schistosomiasis transmission modeling - the sensitivity Analysis
by: Hyun Mo Yang, et al.
Published: (1998-01-01)